SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DECODE GENETICS-*DCGN -- Ignore unavailable to you. Want to Upgrade?

To: tommysdad who wrote (258)10/7/2006 4:37:23 PM
From: keokalani'nui  Read Replies (1) | Respond to of 313
 
Should I be ashamed that my comment was necessarily and sufficiently lame it brought you out after two years gone? If so, I'll gladly play the walter middy again. Nice to see you back in these parts!



To: tommysdad who wrote (258)10/8/2006 11:56:37 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 313
 
Those are strange comments, IMO.

DCGN is a business. How can they justify running two very expensive phase-3 programs in the same indication for two drugs that would cannibalize one another if both programs were to succeed?

Out-licensing 031 and keeping 051—or dropping 031 entirely—are the most likely outcomes, IMO.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News